 | ADC Therapeutics SA (NYSE:ADCT) Receives Average Rating of "Buy" from Brokerages
americanbankingnews.com - November 23 at 7:28 AM |
| ADC Therapeutics (NYSE:ADCT) Trading 6.3% Higher
americanbankingnews.com - November 20 at 6:51 PM |
 | FDA accepts ADC Therapeutics' lonca US application for a type of blood cancer
seekingalpha.com - November 20 at 7:55 AM |
 | ADC Therapeutics Announces FDA Accepts Biologics License Application and Grants Priority Review for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
finance.yahoo.com - November 20 at 7:55 AM |
| Is ADC Therapeutics (NYSE:ADCT) A Risky Investment?
finance.yahoo.com - November 18 at 7:39 AM |
| ADC Therapeutics' (ADCT) CEO Chris Martin on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 5:34 PM |
 | ADC Therapeutics SA: ADC Therapeutics Reports Third Quarter 2020 Financial Results and Provides Recent Business Highlights
finanznachrichten.de - November 12 at 7:33 AM |
| Adc Therapeutics SA to Host Earnings Call
finance.yahoo.com - November 12 at 7:33 AM |
| ADC Therapeutics Reports Third Quarter 2020 Financial Results and Provides Recent Business Highlights
finance.yahoo.com - November 12 at 7:33 AM |
| ADC Therapeutics (NYSE:ADCT) Trading Up 6.1%
americanbankingnews.com - November 11 at 8:03 PM |
|
| Is a Surprise Coming for ADC Therapeutics (ADCT) This Earnings Season?
finance.yahoo.com - November 11 at 3:23 PM |
| ADC Therapeutics (ADCT) to Release Earnings on Thursday
americanbankingnews.com - November 6 at 1:50 PM |
| ADC Therapeutics (NYSE:ADCT) Trading 5.5% Higher
americanbankingnews.com - November 4 at 8:42 PM |
| ADC Therapeutics Announces Eight Presentations on Data from its Next-Generation Antibody Drug Conjugates at the 62nd American Society of Hematology Annual Meeting
finance.yahoo.com - November 4 at 1:14 PM |
| ADC Therapeutics SA's Lock-Up Period To End on November 11th (NYSE:ADCT)
americanbankingnews.com - November 4 at 1:10 AM |
| Early-stage study commences on ADC antibody-drug conjugate in solid tumors
seekingalpha.com - November 3 at 9:37 AM |
| ADC Therapeutics Announces First Patient Dosed with Camidanlumab Tesirine (Cami) in Combination with Pembrolizumab in Ongoing Phase 1b Clinical Trial in Selected Solid Tumors
finance.yahoo.com - November 3 at 9:37 AM |
| ADC therapeutics prices equity offering
seekingalpha.com - September 24 at 8:49 AM |
| ADC Therapeutics Announces Pricing of Public Offering
finance.yahoo.com - September 23 at 11:53 PM |
| ADC Therapeutics files U.S. application for lonca in blood cancer
seekingalpha.com - September 21 at 8:20 PM |
 | ADC Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large ...
businesswire.com - September 21 at 8:20 PM |
| ADC Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
finance.yahoo.com - September 21 at 8:20 PM |
| ADC Therapeutics Announces Proposed Public Offering
finance.yahoo.com - September 21 at 8:20 PM |
| ADC Therapeutics' Cami shows encouraging action in early-stage study in solid tumors
seekingalpha.com - September 17 at 1:09 PM |
| ADC Therapeutics's Cami shows encouraging action in early-stage study in solid tumors
seekingalpha.com - September 17 at 8:08 AM |
| ADC Therapeutics Announces Presentation of Preliminary Findings from Phase 1b Clinical Trial of Camidanlumab Tesirine (Cami) in Advanced Solid Tumors at ESMO Virtual Congress 2020
finance.yahoo.com - September 17 at 8:08 AM |
| ADC Therapeutics Announces Publication Highlighting the Potential of Camidanlumab Tesirine (Cami) as a Novel Immuno-oncology Approach for Solid Tumor Cancers
finance.yahoo.com - September 10 at 8:41 AM |
| ADC Therapeutics SA's (NYSE:ADCT) Profit Outlook
finance.yahoo.com - August 20 at 11:28 PM |
|
| ADC Therapeutics SA's (NYSE:ADCT) Profit Outlook
finance.yahoo.com - August 20 at 8:27 AM |
| 57,225,939
businesswire.com - August 19 at 10:27 PM |
| ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 18 at 11:15 PM |
| ADC Therapeutics SA: ADC Therapeutics Reports Second Quarter 2020 Financial Results and Provides Recent Business Highlights
finanznachrichten.de - August 18 at 7:58 AM |
| ADC Therapeutics Reports Second Quarter 2020 Financial Results and Provides Recent Business Highlights
finance.yahoo.com - August 18 at 7:58 AM |
 | ADC Therapeutics S.A.
barrons.com - August 14 at 10:07 AM |
| ADC Therapeutics to Report Second Quarter 2020 Financial Results on August 18, 2020
finance.yahoo.com - August 12 at 6:58 PM |
 | ADC Therapeutics Presents Clinical Data on ADCT-402 and ADCT-301 in Subtypes of Relapsed or Refractory Lymphoma at the 15th
www.bloomberg.com - July 26 at 6:19 PM |
| Karyopharm's XPOVIO Progress And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - July 19 at 1:50 PM |
| Dosing underway in ADC Therapeutics' LOTIS 3 combo trial in blood cancer
seekingalpha.com - July 17 at 9:34 AM |
 | BRIEF-ADC Therapeutics Says U.S. FDA Lifts Partial Clinical Hold On Phase 2 Trial Of Camidanlumab Tesirine
www.reuters.com - July 6 at 9:46 AM |
 | ADC : FDA Lifts Partial Clinical Hold On Pivotal Phase 2 Trial Of Camidanlumab Tesirine
www.nasdaq.com - July 6 at 9:46 AM |
| FDA lifts partial hold on mid-stage study of ADC Therapeutics' camidanlumab tesirine
seekingalpha.com - July 6 at 9:46 AM |
| FDA halts enrollment in mid-stage study of ADC Therapeutics' camidanlumab tesirine
seekingalpha.com - July 6 at 9:46 AM |
| New Ventures Portfolio Company, ADC Therapeutics, Completes $267 Million IPO
finance.yahoo.com - June 30 at 12:51 PM |
| ADC's lonca shows encouraging action in blood cancer studies
seekingalpha.com - June 12 at 3:13 PM |
| ADC conference call June 12 on loncastuximab tesirine data
seekingalpha.com - June 5 at 9:41 AM |
| ADC Therapeutics to Host Conference Call to Highlight Loncastuximab Tesirine (Lonca) Clinical Trial Data Being Presented at Virtual EHA Annual Congress
finance.yahoo.com - June 5 at 9:41 AM |
| 4Bio Capital: 4BIO Capital portfolio company ADC Therapeutics SA closes an upsized IPO of over $267.6 million
www.finanznachrichten.de - May 20 at 8:37 AM |
| ADC Therapeutics Announces Closing of Upsized $267 Million Initial Public Offering and Receipt of the $65 Million First Tranche under Its $115 Million Convertible Credit ...
www.businesswire.com - May 20 at 8:37 AM |
| ADC Therapeutics stock soars 56% in trading debut
finance.yahoo.com - May 20 at 8:37 AM |
| ADC Therapeutics Announces Closing of Upsized $267 Million Initial Public Offering and Receipt of the $65 Million First Tranche under Its $115 Million Convertible Credit Facility with Deerfield
finance.yahoo.com - May 20 at 8:37 AM |
